Abnormal magnesium metabolism in etiology of salt-sensitive hypertension and type 2 diabetes mellitus

Biological Trace Element Research

Volumn 98, Issue 2, 2004, Pages 97-108

  Wells, Ibert C ^a   Agrawal, Devendra K ^a   Anderson, Robert J ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell membranes; Erythrocytes; Essential hypertension; Magnesium; Magnesium binding; Type 2 diabetes mellitus

Indexed keywords

ADENOSINE TRIPHOSPHATE MAGNESIUM; AMINOPEPTIDASE; MAGNESIUM; PENTAPEPTIDE; PHENYLALANYLGLYCYLEUCYLMETHIONINAMIDE; PHENYLALANYLPHENYLALANYLGLYCYLEUCYLMETHIONINAMIDE; SODIUM CHLORIDE; SUBSTANCE P; TACHYKININ; TETRAPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME MECHANISM; ESSENTIAL HYPERTENSION; FEMALE; GENETIC DISORDER; HUMAN; HUMAN CELL; MAGNESIUM METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT;

EID: 2342504478     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/bter:98:2:097     Document Type: Article

References (13)

1. A. L. Lehninger, Biochemistry, 2nd ed., Worth, New York, p. 390 (1975).
2. D. B. Allen and E. R. Greer, Calcium and magnesium metabolism beyond infancy, in Calcium and Magnesium Metabolism in Early Life, R. C. Tsang, ed., CRC, Boca Raton, FL., pp. 136-138 (1995).
3. S. Wallach, L. N. Cahill, F. H. Rogan, et al., Plasma and erythrocyte magnesium in health and disease, J. Lab. Clin. Med. 59, 195-210 (1962).
4. R. L. Searcy, Diagnostic Biochemistry, McGraw-Hill, New York, pp. 373-380 (1961).
5. M. T. Mattingly, W. A. Brzezinski, and I. C. Wells, Decreased cell membrane magnesium in some essential hypertensive patients, Clin. Exp. Hypertens. A 13, 65-82 (1991).
6. I. C. Wells and D. K. Agrawal, Abnormal magnesium metabolism in two rat models of genetic hypertension, Can. J. Physiol. Pharmacol. 70, 1225-1229 (1992).
7. I. C. Wells and A. J. Blotcky, Coexisting independent sodium-sensitive and sodium-insensitive mechanisms of genetic hypertension in spontaneously hypertensive rats (SHR), Can. J. Physiol. Pharmacol. 79, 779-784 (2001).
8. L. M. Resnick, R. K. Gupta, and J. H. Laragh, Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations, Proc. Natl. Acad. Sci. (USA) 81, 6511-6515 (1984).
9. T. Matuura, M. Kohno, Y. Kanayama, et al., Decreased intracellular free magnesium in erythrocytes of spontaneous hypertensive rats, Biochem. Biophys. Res. Commun. 143, 1012-1017 (1987).
10. L. M. Resnick, R. K. Gupta, K. K. Bhargava, et al., Cellular ions in hypertension, diabetes and obesity. A nuclear magnetic resonance spectroscopic study, Hypertension 17, 951-957 (1991).
11. L. Qu and S. L. Stuesse, Influence of substance P on carotid sinus nerve baro- and chemorecptor activity in rabbits, Peptides 11, 955-961 (1990).
12. G. Rendina, Experimental Methods in Modern Biochemistry, Saunders, Philadelphia, p. 161 (1971).
13. +-ATPase regulation in Dahl salt-sensitive and salt-resistant rats, J. Biol. Chem. 263, 11,056-11,058 (1988).